Prophylactic treatment for delayed chemotherapy-induced nausea and vomiting after non-AC based moderately emetogenic chemotherapy: a systematic review of randomized controlled trials.

Support Care Cancer · 2015 · PMC4483187 · PMID 26041480

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

found highly significant CR rates for delayed CINV prophylaxis following non-AC MEC with multiday olanzapine compared to multiday dexamethasone [ 25 ].

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.